Cassidy Turley FHO Announces 82,490 Square Foot Lease Renewal for Genzyme Corporation

Published on March 19, 2012


BOSTON - Cassidy Turley FHO, a leader in the commercial real estate services field with extensive experience in the Boston-area office market, today announced a 82,490-square-feet lease renewal at 55 Cambridge Parkway in Cambridge for Genzyme Corporation, a leading global biotechnology company.   

55 Cambridge Parkway is a Class-A, 275,000-square-foot facility, located on the Charles River.  The nine-story building was constructed in 1985 and features on-site covered parking, a four-story atrium lobby and direct access to a variety of major transportation routes.   

“We were happy to assist this cutting-edge company with its latest site selection process,” said Mike Brown, Senior Managing Director, Principal at Cassidy Turley FHO.  “Genzyme Corporation provides breakthrough medical therapies for patients with rare and unmet medical needs, and we hope our role in facilitating this lease agreement will continue to position this indispensable company for future success.” 

Brown and Managing Principal Joe Fallon of Cassidy Turley FHO’s Corporate Advisory Service Group represented Genzyme Corporation in the transaction.  The landlord, Invesco, was represented by John Miller, Senior Vice President of Lincoln Property Company.

Lincoln Property Company, a national commercial real estate company, provides brokerage, investment sales, property management, appraisal/valuation and development and project management services to a wide range of clients in its Boston office.  In Massachusetts alone, Lincoln Property manages over 12 million square feet of commercial space and is responsible for leasing millions of square feet of space every year.  For more information on Lincoln Property Company’s Boston office, visit: www.LPCBoston.com.

Genzyme Corporation, a Sanofi Company, has pioneered the development and delivery of transformative therapies for patients affected by rare and debilitating diseases for over 30 years.  We accomplish our goals through world-class research and with the compassion and commitment of our employees.  With a focus on rare diseases and multiple sclerosis, we are dedicated to making a positive impact on the lives of the patients and families we serve.  That goal guides and inspires us every day.  Genzyme’s portfolio of transformative therapies, which are marketed in countries around the world, represents groundbreaking and life-saving advances in medicine.  As a Sanofi company, Genzyme benefits from the reach and resources of one of the world’s largest pharmaceutical companies, with a shared commitment to improving the lives of patients.  Learn more at www.genzyme.com.

Cassidy Turley is a leading commercial real estate services provider with more than 3,500 professionals in more than 60 offices nationwide.  The company represents a wide range of clients—from small businesses to Fortune 500 companies, from local non-profits to major institutions.  The firm completed transactions valued at $22 billion in 2011, manages 455 million square feet on behalf of institutional, corporate and private clients and supports more than 28,000 domestic corporate services locations.  Cassidy Turley serves owners, investors and tenants with a full spectrum of integrated commercial real estate services—including capital markets, tenant representation, corporate services, project leasing, property management, project and development services, and research and consulting.  Cassidy Turley enhances its global service delivery outside of North America through a partnership with GVA, giving clients access to commercial real estate professionals across the globe. Please visit www.cassidyturley.com for more information about Cassidy Turley.

Linda M. McDonough
617.279.4571

More Recent Press Releases

  • No results to display...